MIRM MIRUM PHARMACEUTICALS INC
FollowCOM (common), issuer CIK 1759425
Filings received so far for Q3 2026: 6 13F filers report a position in MIRM shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Peetz Christopherdirector, officer (CHIEF EXECUTIVE OFFICER) | 2026-10-06 | +6,892 M | $15.87 | Form 4 |
| Peetz Christopherdirector, officer (CHIEF EXECUTIVE OFFICER) | 2026-10-06 | +5,305 M | $19.19 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| JUNCTURE WEALTH STRATEGIES, LLC | 5,330 | $456K | 0.12% | +515 | 13F-HRTimeline |
| TOTH FINANCIAL ADVISORY CORP | 685 | $58.6K | 0.01% | -9,600 | 13F-HRTimeline |
| GAMMA Investing LLC | 415 | $35.5K | <0.01% | +47 | 13F-HRTimeline |
| Versant Capital Management, Inc | 144 | $12.3K | <0.01% | +74 | 13F-HRTimeline |
| MassMutual Private Wealth & Trust, FSB | 86 | $7.35K | <0.01% | -5 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 44 | $3.76K | <0.01% | -5 | 13F-HRTimeline |
Events
Peetz Christopher acquired 12,197 MIRM shares on 2026-10-06, Form 4 filed 2026-10-06. 0001614740-26-000014
Accepted , ingested